)
CRH (CRH) investor relations material
CRH Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 revenue rose 3% YoY to $11.396B and Adjusted EBITDA was $2.682B, near prior year; net income declined amid impairment losses and cost pressure.
FY26 Adjusted EBITDA guidance is $7.8B–$8.0B, with net income guidance of $3.1B–$3.3B; the outlook includes Arcosa’s expected Q4 contribution.
Infrastructure and reindustrialization demand, pricing momentum and acquisitions supported results, while subdued residential activity and inflation weighed on performance.
Financial highlights
Q3 revenue was $11.396B versus $11.069B; 9M revenue was $29.543B versus $28.031B.
Q3 Adjusted EBITDA was $2.682B versus $2.695B; 9M Adjusted EBITDA was $5.895B versus $5.653B.
Q3 net income was $1.184B versus $1.519B; 9M net income was $2.515B versus $2.753B.
Q3 diluted EPS pre-impairment was $2.09, down 8% YoY; 9M diluted EPS pre-impairment was $4.09, up 1%.
Q3 gross profit was $4.4B, up 3%, with gross margin of 38.8%, down 10 bps; operating income was $1.9B versus $2.1B, including a $178M impairment charge.
Outlook and guidance
FY26 guidance: net income $3.1B–$3.3B, Adjusted EBITDA $7.8B–$8.0B, diluted EPS $4.63–$4.85, Adjusted Diluted EPS $5.37–$5.59, and capex $2.6B–$2.8B.
Guidance reflects inflationary costs and a challenging residential market; it includes Arcosa’s expected Q4 contribution and Velocity costs.
Guidance assumes normal Q4 weather and no major geopolitical or macroeconomic dislocations; further significant trade-policy changes or unforeseen events are excluded.
2027 expectations include positive pricing and margin expansion, supported by infrastructure demand and a full-year Arcosa contribution; overall cost inflation is expected at mid-single digits.
2027 pricing expectations: U.S. aggregates high-single-digit, U.S. cementitious low-single-digit and international cement mid-single-digit.
- Strong organic profit growth and cash generation cut year-end net debt below 3x EBITDA.CRH
H2 2015 - Strong growth and cash generation cut leverage to 1.7x while supporting further growth.CRH
H2 2016 - €3.3bn EBITDA, stronger margins and returns, and major acquisitions positioned for further growth.CRH
H2 2017 - U.S. momentum and cost actions supported 2013 progress as net debt fell EUR 519m.CRH
H2 2012 - H2 momentum improved as portfolio actions and disciplined investment set up a moderate 2014 recovery.CRH
H2 2013 - EBITDA rose 11% in 2014; 2015 priorities were growth, integration and debt reduction.CRH
H2 2014 - Sales rose 5% and EBITDA reached €1.66bn as margins proved resilient.CRH
H2 2011 - Cash discipline and cost savings steadied results as markets began to stabilize.CRH
H2 2010 - Q2 2026 saw strong growth, margin gains, and the Arcosa deal, supporting a positive outlook.CRH
Q2 2026
)
)
)
)
)
)
)
)